300122.SZ · 智飞生物
China A-shares · RS rating 44 · As of 2026-10-14
| Price | 12.75 CNY |
|---|---|
| 1-day change | -2.0% |
| RS rating (overall / 1M / 3M / 12M) | 44 / 58 / 79 / 12 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 17 / 10 / 18 |
| Industry group (rank) | Medical-Biomed/Biotech (68) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -12.9% |
| Distance from 52-week high | +41.4% |
| Market cap (USD) | $4.9B |